AnGes MG,Inc. AnGes MG,Inc. Japanese Site
News Releases
About Us
Projects
For Investors
What's New
Back Numbers
June 30, 2010 : Published Paper Reporting the Results from Collategene Phase III Clinical Trial Performed in Japan Receives the Research Achievement Award of the Asian Society for Vascular Surgery
April 21, 2010 : Medical Journal Publication of Data from "Collategene" Phase III Clinical Study Performed in Japan
December 25, 2009 : Issuance of Notice of Termination of the License Agreement with Transcription Factor Therapeutics, LLC, on NF-κB Decoy
November 24, 2009 : Agreement on SPA with the US FDA for Phase III Clinical Trial for CollategeneTM, a Drug for Ischemic Disease Treatment
November 24, 2009 : Agreement on SPA with the US FDA for Phase III Clinical Trial for CollategeneTM, a Drug for Ischemic Disease Treatment
November 24, 2009 : Product Patent on Dumbbell-Type (Ribbon-Type) E2F Decoy Oligonucleotide Granted in Japan
--- Covering a Circular Oligonucleotide Sequence ---
October 22, 2009 : Patent on New Decoy Oligonucleotide Granted in Japan
—Covering NF-κB/ets chimera (double) decoy—
September 3, 2009 : AnGes MG Project Adopted by NEDO as Next Generation Strategic Business Program
– Development of Drug-Eluting PTA Balloon Catheter –
August 31, 2009 : Project of AnGes MG Subsidiary GenomIdea Adopted as Strategic Basic Technology Sophistication Supportive Program - R&D of New Method for Biopharmaceuticals Manufacturing Using Technology to Maintain Vacuum -
July 29, 2009 : Medical-Use Patent on NF-κB Decoy Oligonucleotide Granted in Japan - Covering Psoriasis -
July 14, 2009 : AnGes Project Selected by R&D Project for Creation of Regional Innovation -Development of Medical Products Based on Functional Peptides Derived from Plant Regeneration Mechanism-
April 27, 2009 : Joint R&D with Morishita Jintan Co., Ltd. -Development of New Products Based on Functional Peptides with Antimicrobial Activity-
April 23, 2009 : Intellectual Property Report was updated
April 15, 2009 : Substance Patent on Dumbbell-Type (Ribbon-Type) NF-κB Decoy Oligonucleotide Granted in Japan -Covering a Circular Oligonucleotide Sequence-
March 26, 2009 : AnGes Project Adopted to Receive NEDO Support - Development of Novel Disinfectants with Antibacterial Peptides -
March 2, 2009 : AnGes Reached a Broad Agreement with the FDA on the Clinical Trial Designs for Their Phase III Study with Collategene™
February 16, 2009 : Announcement about the progress of Allovectin-7® Phase 3 pivotal trial
February 6, 2009 : AnGes MG continues the collaborations of plasmid HGF for Japan market with Daiichi-Sankyo while the US/Europe marketing rights are returned
February 4, 2009 : Efficacy of NF-κB decoy oligodeoxynucleotides for periodontal disease confirmed in an animal study -An academic paper published in the scientific journal, Antioxidants & Redox Signaling-
February 2, 2009 : GenomIdea, a Subsidiary of AnGes MG, Signs a Licensing Contract for GEN0101
   
Copyright 2004 AnGes MG All rights reserved. Contact | Site Map | Site Policy | Privacy Policy